We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.40% | 246.50 | 246.50 | 247.50 | 250.00 | 246.50 | 250.00 | 38,943 | 14:25:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.76 | 1B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/11/2017 07:58 | Given MDC current level of debt this outcome is not unexpected. | dendria | |
20/11/2017 07:26 | Revised bid made at £3.15, this was rejected, Med now out. | andy2205 | |
17/11/2017 21:29 | In a years time Spire will most probably be back above 300p anyway. With their 30% stake Mediclinic would probably return but next year will have to stump up nearer 400p. | justiceforthemany | |
17/11/2017 21:26 | Mediclinic need to stop wasting everyone's time with their LOW ball offer. Stump up another £100M or so which is peanuts in the big picture and get the job done. 325-330p. | justiceforthemany | |
16/11/2017 07:47 | MDC seem to be struggling with the t/o financials: 'Although discussions have continued, no agreement has yet been reached on any of the key terms of an offer.' 'Mediclinic takes a highly disciplined approach to capital allocation and is focused on ensuring that any offer it makes for the remaining share capital of Spire is in the best interests of Mediclinic shareholders.' | dendria | |
02/11/2017 08:59 | I haven't looked it up, but from memory it is 20th November. | mongrels3 | |
01/11/2017 07:55 | So many rns' - I can't find it - can someone remind me of the deadline date they have again to put in a bid?? | rizler | |
29/10/2017 22:55 | 3.50p is pure speculation based on one shareholder stating that is the minimum they would take. Roll on the put up or shut up date. | cyfran101 | |
29/10/2017 11:18 | 350p bid coming. | justiceforthemany | |
27/10/2017 00:22 | Same here che7win, 50p gain in a few days not to be sniffed at. More downside than upside at this point. Good luck to those here for the longer term. Dibbs | dibbs | |
26/10/2017 13:45 | Sold this morning 296.6p, not sure why it's falling. | che7win | |
24/10/2017 22:28 | Woodford topping up at these prices means a better offer is coming - 330p? | justiceforthemany | |
24/10/2017 16:32 | Yesterday, analysts at Berenberg said prospects for Spire, which runs 38 hospitals and two cancer centres, were strong given predicted NHS demand, and Mediclinic should be applauded for spotting the chance to snap up the group cheaply. They said they expected the bid to be an opening salvo from Mediclinic, which has until November 20 to make a formal offer. There has also been speculation that HCA is interested in buying Mediclinic's stake. Mediclinic, which is listed in Johannesburg and London, said it was considering its position. An HCA spokesman said it was 'unable to comment on market rumour or speculation'. | che7win | |
23/10/2017 22:50 | Hospital Corporation America said to be ready to bid. Mediclinic will have to increase offer to 330p-340p | justiceforthemany | |
23/10/2017 11:57 | People often slate Woodford - I said earlier this month he'd been upping his stake at during lows. His Funds (+others) recognised the true value & didn't panic on bad PR. Momentum was back before this - but bids certainly help speed up proceedings. | windsor430 | |
23/10/2017 08:35 | Hospital Corporation of America (HCA) - bidding war? | justiceforthemany | |
23/10/2017 08:21 | I reckon they will have to come back with an offer at minimum 320p, SPI as a company is now in play.I wonder if other companies will join in bidding for it? | che7win | |
23/10/2017 08:20 | Which broker? iii let me buy at 292 | fozzyb | |
23/10/2017 08:09 | Tried to buy more at open, no chance. | che7win | |
23/10/2017 08:03 | P/E of 22 (same rating as Mediclinic) puts this at the 400p level not even accounting for any future growth. | justiceforthemany | |
23/10/2017 08:02 | This was trading at 400p last year | justiceforthemany | |
23/10/2017 08:01 | Their original purchase was for 360p. Needs increasing a lot. 340-350p minimum. | justiceforthemany | |
23/10/2017 07:41 | Nobody goes in with their final offer. A significant portion isn't in cash. Opening share price will be interesting. | homshaw | |
23/10/2017 07:24 | Preliminary offer 298.6p (150p cash; 0.232 new Mediclinic shares per Spire share) has been rejected. I'm not sure how much MDC can afford to up their offer. | dendria | |
22/10/2017 23:03 | cyfran101, True, long term holders could well see this as too cheap. I guess it would get the ball rolling and may entice out other interested parties. I'm not much of a trader, being still mainly invested but I am holding a bit more cash and looking for the occasional shorter term trade when something like SPI catches my eye. Our differing potential happiness with 320p is interesting in the context of different types of investors and their strategies and the resulting hopes/ expectations. Dibbs | dibbs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions